About: Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 19 July 2020

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) artículu científicu espublizáu en xunetu de 2020 (ast) scientific article published on 19 July 2020 (en) наукова стаття, опублікована 19 липня 2020 (uk)
publication date	wds:Q100302649-A88BA228-8E02-4612-9CEB-466C7D3B4DDB
publication date	2020-07-19 00:00:00Z (xsd:dateTime)
cites work	wds:Q100302649-127659E7-FC4D-4DD4-983E-EFBE29A5F99A wds:Q100302649-14181150-9E0C-40A1-9F44-5ED1A6A879CF wds:Q100302649-1D38005A-D1B2-423A-ADE3-BFB2212B3D1E wds:Q100302649-352EA27D-CBCA-457A-8A26-6CB4F79FB191 wds:Q100302649-38D78D48-5900-4C80-9F87-4CA8F3452826 wds:Q100302649-394709C2-4DBD-41D1-86DB-DC863BD874F1 wds:Q100302649-3FF490EE-37E7-4457-8283-093954E7F65D wds:Q100302649-40269E3E-2BC6-4E9F-949F-0CB93896FB13 wds:Q100302649-62FCB8FD-5421-4A5F-8289-650B963DAC32 wds:Q100302649-6E43F02B-FB1A-44B0-9254-740A2CB0A933 wds:Q100302649-7D3EFF6A-4BA6-446B-952F-AD0EAE668745 wds:Q100302649-8756B6F8-2D73-4388-8BEF-C272655F39B6 wds:Q100302649-8A92D511-8071-4225-8C15-B7617F9D7530 wds:Q100302649-92D8FCE0-6AC6-4F90-94B5-E11C16413C9C wds:Q100302649-AAC63C21-16A2-409C-A78F-78F6630CA0E2 wds:Q100302649-C3A4AD9B-9C6A-4A05-BEE0-0FAAFCA2217B wds:Q100302649-C533A9A7-4DAF-4D79-82ED-1ADDFFB66B22 wds:Q100302649-C65F7940-E841-4BBC-BFD5-B691C996F018 wds:Q100302649-DAF4045D-1BD5-41EB-AE10-CFA6811EFC51 wds:Q100302649-EBE9DFEE-F352-4FC2-8CEC-C264685548DF wds:Q100302649-FA40FFBC-3201-4CBB-B084-AD423BF9D3ED
cites work	Time-scale of interleukin-6, myeloid related proteins (MRP), C reactive protein (CRP), and endotoxin plasma levels during the postoperative acute phase reaction. The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. Protease inhibitors targeting coronavirus and filovirus entry Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Respiratory support for patients with COVID-19 infection Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience Remdesivir for the Treatment of Covid-19 — Final Report TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections. Management of COVID-19 Respiratory Distress Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 SARS-CoV-2: a storm is raging Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 Potential new treatment strategies for COVID-19: is there a role for bromhexine as add-on therapy? Covid-19 in Critically Ill Patients in the Seattle Region - Case Series Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes Compassionate Use of Remdesivir in Covid-19
author name string	wds:Q100302649-2AFCB52D-33BD-4F3F-8D11-F4182C440C4A wds:Q100302649-3DED1B47-A28F-493B-B2E7-570F7D025C02 wds:Q100302649-875C4829-3922-4A1A-A27C-ADEE602433A8 wds:Q100302649-8A3F8790-9E44-4F7D-B01A-B49E0608BEBA wds:Q100302649-BF573317-6E5C-4D25-A94A-EEEE46542ED9 wds:Q100302649-E6CE617F-6740-4079-8FE8-E7470830A8C5 wds:Q100302649-FB9509D5-C6AF-4867-92AB-B787E7DFE7C0
author name string	Parviz Saleh Ali Taghizadieh Ramin Tolouian Mojtaba Varshochi Soheil Teimouri Hamed Valizadeh Tahere Vaezi
rdfs:label	Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial (en) Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial (nl)
skos:prefLabel	Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial (en) Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial (nl)
name	Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial (en) Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial (nl)
author	wds:Q100302649-1C845465-68DA-43EF-ADBA-2111751EB605 wds:Q100302649-4D94AF5B-5EC6-41DC-B278-49A8286B4586 wds:Q100302649-65D8DDF6-A2D2-4F04-B000-4DDA293AEC0E wds:Q100302649-D78B892A-B439-4E7B-825F-FDC8F5F83E5B
author	Kenneth Chapman Saeid Safiri Mohammadreza Ardalan Khalil Ansarin
title	wds:Q100302649-B462643A-F8B9-4D6C-B1D3-AFED7ADDCB41
title	Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial (en)
page(s)	wds:Q100302649-08E11393-BB26-48F1-BFF3-A16D625514A1
page(s)	209-215
instance of	wds:Q100302649-40F204FA-14ED-4EB1-922E-11D6F6747222
instance of	scholarly article
main subject	wds:Q100302649-3E31FF52-58D2-4054-96AF-1CF939D15D42 wds:Q100302649-76c053c1-4872-06a1-74f4-8db3959974fd wds:Q100302649-f9c58cdd-4cf9-9c52-672c-9cfdcdf1ea70
main subject	SARS-CoV-2 COVID-19 mortality pharmacology
PubMed ID	wds:Q100302649-5ED882A7-7634-441A-8B71-0ECD404B768B
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32983936
PubMed ID	32983936
published in	wds:Q100302649-9A993727-DB79-41DC-8A26-1227B0864698
published in	BioImpacts BI
issue	wds:Q100302649-8100EFCD-ED7F-4996-AC73-028C6379BAF7
volume	wds:Q100302649-BD008844-1BCC-4832-86D2-E53F31E250E6
issue	4
volume	10
DOI	wds:Q100302649-6EF01574-4FE3-4649-B261-66122AB4E653
DOI	http://dx.doi.org/10.34172/BI.2020.27

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software